As the global economy recovers in 2021 and the supply of the industrial chain improves, the Non-invasive Prenatal Testing market will undergo major changes. The global non-invasive prenatal testing market size was valued at USD 3.60 billion in 2022. It is projected to reach USD 7.96 billion by 2031, growing at a CAGR of 9.2% during the forecast period (20232031).

The global Non-invasive Prenatal Testing industry report provides top-notch qualitative and quantitative information including: Market size (2017-2021 value and 2022 forecast). The report also contains descriptions of key players, including key financial indicators and market competitive pressure analysis.

The report also assesses key opportunities in the market and outlines the factors that are and will drive the growth of the industry. Taking into account previous growth patterns, growth drivers, and current and future trends, we also forecast the overall growth of the global Non-invasive Prenatal Testing market during the next few years. The global Non-invasive Prenatal Testing market size will reach USD million in 2028, growing at a CAGR of % during the analysis period.

Highlights-Regions

The Non-invasive Prenatal Testing market can be split based on product types, major applications, and important regions as follows:

North America
Europe
Asia Pacific
Latin America

Player list
Thermo Fisher Scientific
Illumina, Inc
F. Hoffmann-La Roche Ltd
Pacific Biosciences of California
QIAGEN NV
PerkinElmer Inc
Agilent Technologies Inc.
Beijing Genomics Institute
Koninklijke Philips N.V.
GE Healthcare

Types list
Consumables
Instruments

Application list
Trisomy
Microdeletion Syndrome
Other Applications